Hoth Therapeutics, Inc. (HOTH)
NASDAQ: HOTH · Real-Time Price · USD
0.787
-0.031 (-3.73%)
At close: Dec 24, 2024, 4:00 PM
0.790
+0.003 (0.38%)
After-hours: Dec 24, 2024, 4:56 PM EST
Hoth Therapeutics Employees
As of December 31, 2023, Hoth Therapeutics had 3 total employees, including 2 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,502,526
Market Cap
5.43M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
IM Cannabis | 95 |
Syros Pharmaceuticals | 68 |
Intelligent Bio Solutions | 50 |
Sunshine Biopharma | 44 |
Tenon Medical | 21 |
Organovo Holdings | 20 |
Quantum BioPharma | 17 |
Bio-Path Holdings | 10 |
HOTH News
- 5 weeks ago - Hoth Therapeutics Board of Directors Approves Bitcoin as Treasury Reserve Asset - PRNewsWire
- 2 months ago - Hoth Therapeutics Announces Update on Cancer Therapeutic HT-KIT Results Suggesting the Treatment Effectively Inhibited Tumor Growth in Preclinical Treatment Study - PRNewsWire
- 2 months ago - Hoth Therapeutics Awarded Key US Patent for Groundbreaking Alzheimer's Treatment and Prepares for Clinical Trials of HT-ALZ with Formulation Now Underway - PRNewsWire
- 3 months ago - Hoth Therapeutics Announces Promising Preclinical Results for Alzheimer's Drug HT-ALZ - PRNewsWire
- 3 months ago - Hoth Therapeutics Announces Expansion of Clinical Sites for HT-001 Phase 2a Trial - PRNewsWire
- 3 months ago - Hoth Therapeutics Announces Positive Data from First-of-its-Kind Human Patient Treatment of EGFRI-Associated Skin Toxicities with HT-001 - PRNewsWire
- 4 months ago - Hoth Therapeutics and Aronnax Inc. Enter Master Services Agreement For HT-KIT Cancer Therapeutic - PRNewsWire
- 5 months ago - Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment - PRNewsWire